Gastrointestinal Therapeutics
Indication(s) - ingestion of toxicants, clean the stomach prior to emergency surgery
Contraindications do not induce vomiting if the patient has ingested caustics or petroleum products or if the patient has had recent abdominal surgery, if hernias are present, or if the patient is in severe abdominal pain.
NEW since 2008 Printed notes:
In human medicine, inducing vomiting is no longer recommended in cases of accidental or intentional posoining. Reasons for this include:
That said, it is not clear (to me) whether we should should or should not recommend that owners induce vomiting when pets have ingested poisons. For some poisonings (particularly things like a bottle full of pills), the practice would seem to have some merit. I'd recommend very selectively. By the way, it is not clear that activated charcoal is efficacious enough to warrant its use in these situations either.
Peripheral-acting emetics
Mechanism(s) - irritation of pharynx, esophagus, stomach, duodenum; or stretch of the muscular layer of the stomach or duodenum. Either mechanism evokes normal reflex arc to produce vomiting. These vary in reliability, safety, availability (do you have them).
Saturated sodium chloride solutions
1% copper sulfate
1% zinc sulfate
Neutral salts (sodium chloride, sodium bicarbonate)
Syrup of ipecac
Freshly ground mustard
Hydrogen peroxide
Central-acting emetics
Mechanism(s) - stimulation of chemoreceptor trigger zone (CRTZ) and/or direct stimulation of emetic center
Apomorphine
Morphine
Xylazine
Syrup of Ipecac
Rationale
Peripheral-Acting Antiemetics
Demulcents - Kaolin, Pectin, Bismuth salts
Indication(s): control of vomiting associated with pharyngitis, gastritis. poor efficacy (may even stimulate vomiting)
Antacids - aluminum hydroxide, aluminum phosphate, magnesium hydroxide, etc.
Specific indication: vomiting associated with excess gastric acidity. Efficacy is questionable except to prevent recurrence (may stimulate vomiting in acute cases)
H-2 receptor antagonists - cimetidine, ranitidine, etc.
Specific Indication: vomiting associated with excess gastric acidity. Injectable dose forms will not stimulate vomiting so probably preferred over oral antacids
Local Anesthetics (e.g., Lidocaine viscous)
Specific Indication: vomiting associated with pharyngitis. Poor efficacy, may stimulate vomiting
Anticholinergics - aminopentamide, atropine, scopolamine
Indications are non-specific. Peripheral action alleged - block sensory input to CNS. Effective drugs in this class also have central action
Metoclopramide
Indications for regurgitation, pylorospasm. Improves coordination of motility and gastric emptying. Also possesses central action (CRTZ) described below
Central-acting antiemetics
Potential Sites of Action for the Central-acting antiemetics include the, vestibular apparatus, the chemoreceptor trigger zone (CRTZ), and the emetic center. Central-acting Anti-emetic drugs may be limited spectrum (one, maybe two sites) or broad spectrum (multiple or all sites).
Limited Spectrum Anti-emetics
Anticholinergic - aminopentamide (Centrine® ), scopolamine
Anti-histamines (H-1 receptor)
Short duration (4-8 hours) - diphenhydramine, dimenhydrinate
- motion sickness
Long duration (12 -24 hours) - meclizine, promethazine
- motion sickness
- vestibular disease (usually inflammation)
Trimethobenzamide
Metoclopramide
ondansetron, ganesetron (5-HT3 receptor blockers)
Maropitant (CereniaTM Dog); aprepitant (Emend Human) (NK-1 receptor blocker)
Broad-spectrum anti-emetics
block more than one site
Phenothiazines - chlorpromazine, acepromazine, prochlorperazine
Actions:Increase Gastrointestinal Motility
Gastrointestinal motility is influenced by hormonal activity, myogenic activity (contractile response to stretch), and neurogenic factors. It is divided into rhythmic segmentation (mixing activity and "average GI tone") and peristaltic activity (mainly propulsive).
Cholinergic Drugs
Rationale Cholinergic drugs are used for symptomatic treatment for diminished gastrointestinal motility (ruminal atony, abomasal displacement, ileus). Unfortunately they produce an uncoordinated increase in motility (coordinated would be preferred - see metoclopramide) You may see evidence of activity (abdominal pain, cramping) without improving patient condition
Pilocarpine
- marked effects on all muscarinic sites
- readily antagonized by atropine
Bethanechol - (Urecholine®)
- selective for smooth muscle stimulation
- readily antagonized by atropine
- terminated by elimination (not by cholinesterases)
Carbachol
- relatively selective for smooth muscle
- may stimulate nicotinic receptors at therapeutic doses
- muscle fasciculations
- sympathetic stimulation - antagonizes smooth muscle actions
- poorly antagonized by atropine
Pantethol
- converted to pantothenic acid, a precursor of Coenzyme A
- ultimate action related to increase in acetylcholine production
- QUACK, QUACK, QUACK
Cholinesterase inhibitors
These agents increase concentrations of acetycholine at the nerve terminal. The net effect is the same as if a direct-acting cholinergic agent were administered though the ultimate effect may be less predictable.
Physostigmine (tertiary amine)
- oral absorption possible but variable
- dose vs response is unreliable
Neostigmine (quarternary amine)
- no oral absorption
- may stimulate cholinergic receptors directly
- most reliable of the two cholinesterase inhibitors
Cathartics, Surfactants, Lubricants
Indications these drugs are indicated for bowel cleansing (pre-surgical, pre-radiography, pre-proctoscopy), to promote elimination of toxicants, to facilitate defecation (hernias, surgeries) and to alleviate simple constipation
Irritant Cathartics
Mechanism stimulate smooth muscle directly
Contraindications
Arthroquinone derivatives - aloe, senna, cascara sagrada and danthron (synthetic)
- hydrolized in colon
- variable onset (6 - 12 hour delay)
- unreliable
- produce considerable discomfort
Phenylphthalein
- swine and primates only
- 6 - 8 hour delay
- pink urine (if alkaline)
Bisacodyl
- hydrolyzed in small intestine to produce irritating sodium and potassium salts
- more predictable and reliable than arthroquinone
"Saline" Cathartics
Sodium sulfate
- most effective on a molar basis
- must be administered by stomach tube
Magnesium salts (oxide, hydroxide, sulfate)
- most are also used as antacids
- generally balanced with aluminum salts (aluminum constipates) when used for antacid action only
- magnesium toxicity only with increased GI transit times or renal dysfunction
- suitable for dogs, cats, foals, calves, piglets
Hydrophilic colloids (bran mash, linseed mash, psyllium)
Polyethylene Glycol Electrolyte (Go-LYTELY®)
Lubricants
Liquid petrolatum (mineral oil), petrolatum (vasoline, Cat-a-lax®)
- used in feline (petrolatum), equine, and bovine (liquid petrolatum) patients
- not for household pet animals (loss of defecatory control)
- foreign body reactions in intestinal wall
- avoid following rectal-anal surgery (oil foreign-body in wound)
Raw linseed oil
- mechanism as for liquid petrolatum
- no foreign body reactions
Surfactants
Mechanism non-irritating soaps that facilitate movement of water into fecal mass. These are classically referred to as "stool-softeners". Can be given as enemas or by mouth.
Caution. These may facilitate absorption of mineral oil when the two are given together
Dioctyl sodium sulfosuccinate and Dioctyl calcium sulfosuccinate
Prokinetic Agents
Metoclopramide
Mechanism Effect is probably mediated through both cholinergic systems enhanced and dopaminergic systems blocked.
Indications Pylorospasm and associated gastric reflux, presurgical emptying of the stomach, to facilitate passage of endoscope (maybe not in veterinary patients - per M.Leib), prevention of gastric dilatation and volvulus, displaced abomasum (investigational)
Cisapride
Mechanism Increase release of acetylcholine from postganglionic nerve endings of myenteric plexis. Both large and small bowel motility are enhanced
Indications Gastroesophageal reflux disease, Gastric atony uses in ileus, large bowel hypomotility speculative (clinical trials are sparse) but are probably appropriate given the limited number of alternatives.
"Investigational Prokinetics" - Erythromycin, Lidocaine
Alter gastrointestinal motility to control small bowel diarrhea.
Opiates
Mechanism(s)Increase tone in intestinal smooth muscle, increase rhythmic segmentation as compared to peristalsis, enhances fluid absorption, decreases average "lumen diameter". Decrease intestinal secretion (second action discussed later)
Indications Controlling signs of small bowel diarrhea
Loperamide (Imodium)
- mixed agonist/antagonist with "no" abuse potential
- available over the counter
- liquid forms available
Diphenoxylate (Lomotil)
- mixed agonist/antagonist with relatively low abuse potential
- alter motility with few systemic effects
Paregoric (tincture of opium)
- occasionally preferred for small dogs, though loperamide is probably the drug of choice.
Decreased gastrointestinal motility
Management of drug induced "increased motility" or know these side effects when drugs are used for other purposes
Anticholinergic Drugs
Mechansim(s) Decrease parasympathetic tone in the gastrointestinal tract. Administration of these drugs is VERY questionable for the treatment of small bowel diarrhea, simply because gastrointestinal motility and associated disorders are controlled by a VERY complex set of neurogenic inputs that include a variety of other mediators. Further, many small bowel diarrheal diseases actually include low motility as a significant feature.
Indications Overzealous administration of cholinergic drugs and cholinesterase inhibiters, organophosphate and carbamate intoxication. Use in diarrhea may prolong clinical signs and may produce ileus (signs of which may include diarrhea)
atropine, scopolamine
- cross into central nervous system
- depression (most species), excitement (cats)
methscopolamine, propanthaline, isopropamide (Darbazine®)
- quarternary nitrogen (do not reach CNS)
- may also inhibit nicotinic receptors (ganglia)
Adrenergic Drugs
Reduced GI motility is a side effect of administration for other purposes
a-1 agonists
Management of Severe Visceral Pain
Caution: although is is part of the veterinarian's oath to alleviate pain and suffering, pain may be the most (or only) useful clinical sign to the veterinary therapist as a guide to the animals response to other therapy. Relief of visceral pain should never be the ONLY therapy employed and may, in fact, be contraindicated early in the management of certain conditions.
Central Acting Analgesics
Mechanism(s) Raise the threshold for pain, decrease the reaction to pain, and promote drowsiness
Opiates / Opioids
Morphine
- most versatile, least expensive
- Duration = 6 hours in dogs and cats, 2 + in horses (depends on severity of pain)
- Progressive depression in dogs, rabbits
- Progressive excitement in horses, cats, swine
- Little or no action in ruminants
Methadone
- equal potency to morphine
- preferred by some to produce analgesia without excitement in horses
Meperidine
- 1/10 the potency of morphine
- short duration (Horses - 20 minutes; Cats - 2 hours; Dogs - 45 minutes)
- excessive doses may produce seizures
Oxymorphone
- potency 10x that of morphine
- little real advantage over morphine
Pentazocine
- potency 1/4 of morphine
- agonist/antagonist (lower abuse potential)
- short duration (Horse - 2 hours; Dogs and Cats - 1 hour or less)
Butorphanol
- potency 4x - 7x morphine
- agonist/antagonist (very low abuse potential)
Non-narcotic Analgesics
a 2 Agonists (Xylazine, Detomadine, Metdetomidine)
"Peripheral Acting Analgesics" - NSAIDS
Useful for the relief of visceral pain associated with intestinal spasm triggered by inflammatory mediators. Only flunixin meglumine and ketoprofen (of available agents) reduce gastrointestinal pain by other means. Mechanism of action of these compounds is discussed under anti-inflammatory drugs (http://cpharm.vetmed.vt.edu/VM8784/nsaids/nsaids.htm). Agents mentioned here enjoy special action or reputation for GI therapeutics.
Flunixin meglumine
- potent analgesic in the horse and ruminants
- duration of action may be too long (see colic)
Ketoprofen
- clinically, this seems to be very similar to flunixin meglumine
- head-to-head comparisons are just beginning in the literature
Decrease flow of Saliva
see anesthesia notes
Decrease Gastric Acid Secretion
Anticholinergics
although these agents may decrease the secretion of gastric acid, there efficacy is very poor because acetylcholine is not a primary mediator for acid secretion
Anti-histamines (H-2 receptor blockers)
Cimetidine (Tagamet® )
Ranitidine (Zantac® )
Famotidine (Pepsid® )
Hydrogen ion-pump blockers
Omeprazole - (GastroGard® , Prilosec®, Nexium® AcipHex® , etc., etc.)
Mechanism block hydrogen ion secretion by direct inhibition of an ATPase
Indications Conditions related to hyperacidity refractory to other H-2 blockers. Approved indication in horses for treatment of gastric ulcers and prevention of recurrance.
Protect mucous membranes
Barium sulfate
Bismuth subsalicylate
Sucralfate
Misoprostol
Modify Intestinal Secretion
A number of different drug classes, including non-steroidal anti-inflammatories and opiates alter intestinal secretion. In fact, this may be a major mechanism of their activity in the treatment of small and large bowel diarrheas. In addition, oral electrolyte solutions serve as a valuable adjunct to therapy in neonatal diarrheas. Their primary activity is to maintain circulating blood volume, but they do so by fostering intestinal absorption of electrolytes and fluids in opposition to disease-induced secretion.
Topic Summary (Gastrointestinal Tract)
| Antihistamines | vestibular | motion sickness | |
| Phenothiazines | CRTZ | drug/toxin induced | |
| Phenothiazines | Emetic Center | all causes | |
| Metoclopramide | CRTZ | drug/toxin induced | |
| Metoclopramide | Peripheral | abn. GI function | |
| Butyrophenones | Vestibular | Labyrinthitis | |
| Butyrophenones | Emetic Center | All causes |